|
![]() |
|||
|
||||
OverviewTopics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Role of novel mutations in MPN pathogenesis and outcome; Role of JAK inhibitors in MPN treatment; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis. Full Product DetailsAuthor: Ross Levine, MDPublisher: Elsevier Health Sciences Imprint: W B Saunders Co Ltd Volume: 26-5 Dimensions: Width: 16.20cm , Height: 1.60cm , Length: 23.60cm Weight: 0.400kg ISBN: 9781455749416ISBN 10: 1455749419 Pages: 240 Publication Date: 10 October 2012 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationHuman Oncology and Pathogenesis Program. Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Tab Content 6Author Website:Countries AvailableAll regions |